VEGFA and cancer: ,251 In a clinical trial, cationic liposomes carrying anti-vascular endothelial growth factor (VEGF) and anti-kinesin spindle protein (KSP) siRNA, known as ALN-VSP, showed an increased uptake in tumor cells and significant downregulation of VEGF and KSP levels when administered to patients with multiple types of cancer (Table 2).51